Finance

Lists
Why is ARQT up 8,53%?
Dive Deeper
ARQT:NASDAQ
Arcutis Biotherapeutics Inc
26,58 $
+8,53%
(+2,09) 1D
26,45 $
-0,49% (-0,13)
After hours
Closed: 9 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARQT...
Open
24,50 $
High
26,97 $
Low
24,30 $
Mkt. cap
3,34 մլրդ
Avg. vol.
3,00 մլն
Volume
1,73 մլն
P/E ratio
123,91
52-wk high
31,77 $
52-wk low
19,30 $
EPS
0,21 $
Beta
1,57
Shares outstanding
125,69 մլն
No. of employees
354
Open
24,50 $
High
26,97 $
Low
24,30 $
Mkt. cap
3,34 մլրդ
Avg. vol.
3,00 մլն
Volume
1,73 մլն
P/E ratio
123,91
52-wk high
31,77 $
52-wk low
19,30 $
EPS
0,21 $
Beta
1,57
Shares outstanding
125,69 մլն
No. of employees
354
News stories
From web sources and news partners
About Arcutis Biotherapeutics Inc
CEOFrank Watanabe
Employees354
Founded2016
HeadquartersWestlake Village, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to ARQT in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ARQT in the last 3 months.
Highest
Current 26,58 $
40,00 $ (+50,49%)
Average
37,00 $ (+39,20%)
Lowest
34,00 $ (+27,92%)
Analyst
Recommendation
Action
Price target
Projected
Date
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
34,00 $
+27,9%
08/10/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
38,00 $
+43%
08/06/2026
Serge Belanger
Needham
Buy
Reiterated
40,00 $
+50,5%
08/06/2026
Seamus Fernandez
Guggenheim
Buy
Reiterated
38,00 $
+43%
08/05/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
35,00 $
+31,7%
08/05/2026
Uy Ear
Mizuho Securities
Buy
Reiterated
36,00 $
+35,4%
08/06/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
35,00 $
+31,7%
07/16/2026
Unknown Analyst
Jefferies
Buy
Maintained
35,00 $
+31,7%
07/09/2026
Richard Law CFA
Goldman Sachs
Hold
Maintained
33,00 $
+24,2%
02/27/2026
Last report
05 օգս, 2026 թ.
Fiscal period
Q2 2026
0,11 $ / 0,05 $
+120,00%beat
Revenue / Est. (USD)
129,86 մլն / 118,85 մլն
+9,26%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
99,22 մլն
129,50 մլն
105,40 մլն
129,86 մլն
Cost of goods sold
8,68 մլն
11,69 մլն
9,78 մլն
10,94 մլն
Cost of revenue
8,68 մլն
11,69 մլն
9,78 մլն
10,94 մլն
Research and development expenses
19,60 մլն
20,45 մլն
30,63 մլն
20,36 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
62,40 մլն
78,98 մլն
74,08 մլն
82,14 մլն
Operating expense
82,01 մլն
99,43 մլն
104,70 մլն
102,49 մլն
Total operating expenses
90,69 մլն
111,12 մլն
114,49 մլն
113,43 մլն
Operating income
8,53 մլն
18,39 մլն
-9,09 մլն
16,43 մլն
Other non operating income
-
443,00 հզր
-20,00 հզր
-157,00 հզր
EBT including unusual items
7,49 մլն
17,86 մլն
-11,20 մլն
15,14 մլն
EBT excluding unusual items
7,49 մլն
17,86 մլն
-11,20 մլն
15,14 մլն
Income tax expense
80,00 հզր
470,00 հզր
93,00 հզր
136,00 հզր
Effective tax rate
1,07%
2,63%
-0,83%
0,90%
Other operating expenses
-
-
-
-
Net income
7,41 մլն
17,40 մլն
-11,30 մլն
15,01 մլն
Net profit margin
7,47%
13,43%
-10,72%
11,56%
Earnings per share
0,06
0,13
-0,09
0,11
Interest and investment income
2,04 մլն
2,04 մլն
2,28 մլն
2,28 մլն
Interest expense
-3,07 մլն
-3,00 մլն
-4,37 մլն
-3,41 մլն
Net interest expenses
-1,04 մլն
-965,00 հզր
-2,09 մլն
-1,13 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
9,09 մլն
18,95 մլն
-8,53 մլն
16,99 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps